Evaluation of the QuantaMatrix Multiplexed Assay Platform for Molecular Diagnosis of Multidrug- and Extensively Drug-Resistant Tuberculosis Using Clinical Strains Isolated in Myanmar

BACKGROUND: Although the incidence of tuberculosis (TB) is decreasing, cases of multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB continue to increase. As conventional phenotype drug susceptibility testing (pDST) takes six to eight weeks, molecular assays are widely used to determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yunhee, Kim, Seoyong, Kim, Yeun, Ei, Phyu Win, Hwang, Dasom, Lee, Jongseok, Chang, Chulhun L, Lee, Hyeyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821996/
https://www.ncbi.nlm.nih.gov/pubmed/31650730
http://dx.doi.org/10.3343/alm.2020.40.2.142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821996/
https://www.ncbi.nlm.nih.gov/pubmed/31650730
http://dx.doi.org/10.3343/alm.2020.40.2.142

Ejemplares similares